Search | Result
| ID | 1711 |
|---|---|
| Class | Mammalia |
| Species | Homo sapiens |
| Tissue | Breast |
| Sample | Cell line |
| Disease type | Triple-Negative Breast Cancer |
| Cell type | Bbdi-resistant cells |
| Cell type (subtype) | Bbdi-resistant cells |
| Cell marker | CDK4, CCND1, BCL2L1 |
| Frequency | |
| PubMed ID | 32416067 |
| Journal | Molecular Cell |
| SCI IF | 15.584 |
| Evidence | Similarly, BBDI-resistant and parental cells separated very clearly, and BBDI-resistant cell cluster-specific genes included several CRISPR screen hits, such as CDK4, CCND1, and BCL2L1 (Figures 7A and S7A). |
| Title | Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer |
| Authors | Shaokun Shu et al. |
| Date | 2020.6 |
| Data available | GSE131102 |
